Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Cerezyme (imiglucerase for injection)[1] Imiglucerase (Imiglucerase)[2] Alglucerase ,
Imiglucerase (Imiglucerase) 💬
[1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
2Cerezyme 400 Units Powder for concentrate for solution for infusionPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: ImigluceraseCAS Number: 154248-97-2Concentration unit: U unit(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use----[1] 19 💬
3Cerezyme® / Imiglucerase[1] Imiglucerase (Imiglucerase)[2] Alglucerase ,
Imiglucerase (Imiglucerase) 💬
[1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
4IMIGLUCERASE[1] Imiglucerase (Imiglucerase)[2] Alglucerase ,
Imiglucerase (Imiglucerase) 💬
[1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
5Imiglucerase GZ437843[1] Imiglucerase (Imiglucerase)[2] Alglucerase ,
Imiglucerase (Imiglucerase) 💬
[1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬